Cello Therapeutics, Inc. — Form D
Cello Therapeutics, Inc. of San Diego, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-06-23. The offering totals $10.0M, of which $1.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-06-23
- Form: D
- Accession: 0001708130-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $1.6M
- Remaining: $8.4M
- Investors: 5
- Date of first sale: 2017-06-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-289349
Issuer
- Name: Cello Therapeutics, Inc.
- CIK: 0001708130
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 5945 Pacific Center Blvd., Suite 507, San Diego, CA, 92121
- Phone: 858-412-4156
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Lili Xie | Director | San Diego, CA |
| Jie Zhang | Director | San Diego, CA |
| Jie Zhang | Executive Officer | San Diego, CA |
| Liangfang Zhang | Director | San Diego, CA |
| Huiqing Zhu | Director | San Diego, CA |
| Wei Shen | Director | San Diego, CA |
Other filings by this issuer (1)
More